Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-ba...

por Chien, S-H, Liu, C-J, Hong, Y-C, Teng, C-J, Hu, Y-W, Shen, C-C, Ku, F-C, Chen, S-C, Yeh, C-M, Chiou, T-J, Gau, J-P, Tzeng, C-H
Publicado 2015